Fellowship for Scholars
The James F. Drane Bioethics Institute awards fellowship status to scholars (preferably with affiliation to academic centers) and graduate students (preferably PhD candidates who are working on their dissertations) from the United States or abroad whose scholarly works or projects are related to bioethics.
Each Fellow spends between one and six months at the Institute. During the time of fellowship, the Fellow resides at Edinboro University, using the resources available at the Institute, working with Edinboro University faculty, and participating in University events and activities.
The Fellow may also participate in the events sponsored by other academic centers in the region, especially the Center for Healthcare Ethics at Duquesne University in Pittsburgh.
The institute has a limited fund to cover the travel and accommodation expenses for Fellows each year.
What we provide:
What we expect:
Funding and the final certificate will depend on:
How to apply:
To apply for the Fellowship, please email the following items to Dr. Kiarash Aramesh (Email address: firstname.lastname@example.org):
For fellowship opportunities in the spring and summer of 2019, please submit your application by January 1, 2019.
James F. Drane Bioethics Institute Fellow, April-May, 2019
Stephen is a doctoral candidate in Philosophy at the University of Missouri. His dissertation focuses on the ethics of belief and how agents can be responsible for their beliefs. Over the course of his time at the University of Missouri, Stephen has devoted his time to bioethics, organizing a conference on the ethics of germline genetic modification, and teaching classes in the subject.
As a James F. Drane Fellow, Stephen has two main research projects at Edinboro. First, he is interested in the ethics of tobacco harm reduction policies that encourage active smokers to switch to e-cigarette products as a means to prevent deaths related to combustible tobacco usage. Tobacco harm reduction policies tend to only encourage switching in more advantaged communities. His main concern is whether we have an ethical obligation to gear harm reduction policies towards the needs of disadvantaged communities, especially in middle- and lower-income countries.
Stephen’s second interest is in the ethics of germline genetic modification. One of the primary targets for germline genetic modification are fetuses that contain the genetic markers for disabilities. The idea, here, is that modifying a fetus so that it will not possess a disability is therapeutic. Most think that therapeutic genetic modification is permissible. Stephen’s is interested in whether the removal of a disability can constitute genetic therapy. He argues that possessing a disability does not make a person inherently worse off than one who does not possess a disability.